Resources & Media

Recent Statements

Statement on Rep. Matsui Introduction of SERV Communities Act
The bill would bring relief to essential hospitals and their patients from damaging Medicare outpatient payment cuts and much-needed accountability for manufacturers in the 340B Drug Pricing Program. (June 12, 2018)

HRSA Should Revisit Delay of 340B Rule
The delay enables manufacturer overcharges that jeopardize access to affordable drugs for vulnerable patients and drive up costs for hospitals. (June 1, 2018)

Statement on Avalere Analysis of 340B Payment Policy in 2018 OPPS
This badly misleading report makes no attempt to focus on or isolate the 340B drug payment policy. Rather, it masks the policy’s damaging impact by conflating it with other unrelated policy changes. (Jan. 29, 2018)

Issue Briefs and Comment Letters

Our View: 340B Protects Patients and Communities from High Drug Prices (June 2018)

Letter to the Health Resources and Services Administration on the delay of a final rule on ceiling prices and manufacturer civil monetary penalties (May 22, 2018)

Print and Social

Informational Fliers

Print and share these two-page PDF fliers.

340B HELPS HER FIGHT TO LIVE. FULL POCKETS. EMPTY BOTTLES. 340B IS JUST WHAT THE DOCTOR ORDERED. DON'T TAKE THE POISON PILL DRUG COMPANIES ARE SELLING FOR 340B. TAKE THE BAIT, AND YOU'LL BE ON THE HOOK FOR HIGHER DRUG PRICES.
Share Graphics

Click and then right click to download full-size images.

340B HELPS HER FIGHT TO LIVE. FULL POCKETS. EMPTY BOTTLES. 340B IS JUST WHAT THE DOCTOR ORDERED. DON'T TAKE THE POISON PILL DRUG COMPANIES ARE SELLING FOR 340B. TAKE THE BAIT, AND YOU'LL BE ON THE HOOK FOR HIGHER DRUG PRICES.